| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-07-15 | Ebola prime-boost vaccine regimen (MVA-BN® Filo vaccine with the Ad26.ZEBOV vaccine) | Ebola fever | 2 | Oxford Vaccines Group (UK) | Infectious diseases |
| 2015-07-15 | MDGN-201 (TARGTEPO™), formerly known as EPODURE™ | anemia of end stage renal disease | 2 | Medgenics (USA - Israel) | Kidney diseases - Renal diseases |
| 2015-07-15 | talimogene laherparepvec | hepatocellular carcinoma | 1 | Amgen (USA - CA) | Cancer - Oncology |
| 2015-07-15 | masitinib in combination with gemcitabine | refractory advanced or metastatic epithelial ovarian cancer | 2-3 | AB Science (France) | Cancer - Oncology |
| 2015-07-15 | CER-001 | carotid plaques in patients with advanced atherosclerotic disease | Cerenis Therapeutics (France) | Cardiovascular diseases | |
| 2015-07-14 | BLZ-100 - chlorotoxin conjugated to indocyanine green dye | solid tumors |
1 | Blaze Biosciences (USA - WA) | Cancer - Oncology |
| 2015-07-14 | AC-1204 (caprylic triglyceride) | Alzheimer\'s disease | 2-3 | Accera (USA - CO) | Neurodegenerative diseases |
| 2015-07-13 | FPA008 (cabiralizumab) | pigmented villonodular synovitis (PVNS) |
1-2 | Five Prime Therapeutics (USA - CA) | Rare diseases - Inflammatory diseases |
| 2015-07-13 | MN-166 (ibudilast) | multiple sclerosis | 2 | Medicinova (USA - CA) | Autoimmune diseases - Neurodegenerative diseases |
| 2015-07-13 | SMT022357 | Duchenne muscular dystrophy | preclinical | Summit Therapeutics (UK) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2015-07-13 | TXA127 (angiotensin) | amyotrophic lateral sclerosis (ALS) | preclinical | Tarix Orphan (USA - MA) | Neurodegenerative diseases - Rare diseases |
| 2015-07-13 | durvalumab (MEDI4736) and tremelimumab | urothelial cancer | 3 | AstraZeneca (UK) | Cancer - Oncology |
| 2015-07-12 | Grass MATA MPL | grass allergic rhinitis | 2 | Allergy Therapeutics (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2015-07-12 | Viaskin® Peanut | peanut allergy | 3 - pediatric | DBV Technologies (France) | Allergic diseases |
| 2015-07-12 | tazemetostat - EPZ-6438 (E7438) | advanced solid tumors B cell lymphomas | 1 | Epizyme (USA - MA) Eisai (Japan) | Cancer - Oncology |
| 2015-07-11 | RNActive® vaccine CV9103 | advanced castration-resistant prostate cancer | 1-2 | Curevac (Germany) | Cancer - Oncology |
| 2015-07-10 | long-acting recombinant human growth hormone analog (Mod-4023) | adult growth hormone deficiency | 3 | Opko Health (USA - Fl) | Genetic diseases - Endocrine diseases - Hormonal diseases |
| 2015-07-09 | tazemetostat - EPZ-6438 (E7438) | diffuse large B-cell lymphoma, follicular lymphoma | 2 | Epizyme (USA - MA) | Cancer - Oncology |
| 2015-07-09 | Adcetris® (brentuximab vedotin) | systemic lupus erythematosus (SLE) |
2 | Seattle Genetics (USA - WA) | Autoimmune diseases |
| 2015-07-08 | Praluent® (alirocumab) | patients with hypercholesterolemia at high cardiovascular (CV) risk, heterozygous familial hypercholesterolemia (HeFH), | 3 | Sanofi (France) Regeneron Pharmaceuticals (USA - NY) | Cardiovascular diseases - Genetic diseases - Rare diseases |
